Showing results (101-110 of 541) with videos related to

Sort By:
Pageof 55
Drugs - Real World Outcomes|December 21, 2023
Post Hospitalization Clinical Quality Outcomes Among US Patients with Schizophrenia Treated with a Long-Acting Injectable or Switched to a New Oral Antipsychotic: A Retrospective Cohort StudyCharmi Patel, Seth Emont, Zhun Cao, et al.
Drugs - Real World Outcomes|November 28, 2023
Association of Antipsychotic Drugs with the Risk of Recurrent Venous Thromboembolism: A Retrospective Study of Data from a Japanese Inpatient DatabaseHiroyuki Hashimoto, Shinobu Imai, Ryoka Yamashita, et al.
Drugs - Real World Outcomes|February 14, 2024
An Observational Study to Determine the Real-Life Effectiveness of MP-AzeFlu® in Austrian Patients with Persistent Allergic RhinitisKatharina Marth, Andreas Renner, Georg Langmayr, et al.
Drugs - Real World Outcomes|June 3, 2024
Real-World Evidence on Levetiracetam-Induced Hypokalemia: An Active Comparator Cohort StudyOhoud Almadani, Raseel Alroba, Almaha Alfakhri, et al.
Drugs - Real World Outcomes|October 19, 2023
Signal Detection and Assessment of Herb-Drug Interactions: Saudi Food and Drug Authority ExperienceWaad Alghamdi, Nouf Al-Fadel, Eman A Alghamdi, et al.
Drugs - Real World Outcomes|October 11, 2023
Impact of Risk Minimisation Measures on Valproate Use among Women of Reproductive Age in Latvia Between 2013 and 2020: A 7-Year Nationwide Prescription Database StudyIeva Rutkovska, Andis Seilis, Zane Neikena, et al.
Drugs - Real World Outcomes|September 28, 2023
Efficacy of Three Teriparatide Preparations and Romosozumab, Osteogenesis Promoters, in the Treatment of Fresh Vertebral Fractures: A Retrospective Observational StudyKouken Hayashi
Drugs - Real World Outcomes|September 22, 2023
Analysis of Pregnancy Outcomes Following Exposure to Intramuscular Interferon Beta-1a: The AVONEX® Pregnancy Exposure RegistryBianca Weinstock-Guttman, Amy Perrin Ross, Jonathan Planton, et al.
Drugs - Real World Outcomes|September 21, 2023
Treatment Patterns by Race and Ethnicity in Newly Diagnosed Persons with Multiple SclerosisCaroline Kelley Geiger, Daniel Sheinson, Tu My To, et al.
Drugs - Real World Outcomes|October 9, 2024
Early Clinical Outcomes of Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma: A Real-World Comparison with First-Line or Later-Line TreatmentYudai Fujiwara, Hidekatsu Kuroda, Tamami Abe, et al.
Pageof 55